We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

BioTek

BioTek Instruments, Inc., designs, manufactures, and distributes life science instrumentation. Its product line inclu... read more Featured Products: More products

Download Mobile App




Newly Augmented Microdispenser System Replaces Five Liquid Handling Instruments

By LabMedica International staff writers
Posted on 13 Apr 2014
Upgrades to a highly regarded microdispenser system allows the instrument fo replace up to five separate liquid handlers, saving operator time and instrumentation costs

The new BioTek (Winooski, VT, USA) MultiFlo FX Microplate Dispenser is now available with optional RAD (Random Access Dispense) technology to further extend its application range and flexibility. More...
RAD technology offers single-channel dispensing to random individual microplate wells along with rapid reagent dispensing into large volume wells of 6- to 24-well microplates. MultiFlo FX can also be separately configured with an optional wash module for 6- to 384-well plates.
The Multiflo FX accommodates microplate types ranging from 6- to 1536-wells, and dispenses volumes of from one to three microliters accurately and precisely. BioTek's proprietary angled dispensing ensures compatibility with all dispense protocols including media exchanges with loosely adherent cell monolayers. For assays requiring minimum reagent usage, the MultiFlo's prime volume is less than one milliliter. A built-in priming trough is designed to allow both recovery of reagents or to send primed reagent directly to waste.

MultiFlo FX was especially designed for sensitive cell-based assays, ELISAs, and bead-based assays, with angled dispense tips and flexible flow rates to maintain cell integrity.

Due to its small footprint and base height of less than 20.3 cm, the MultiFlo FX readily fits on any laboratory bench or robotic system. It is easily integrated with the BioTek BioStack Microplate Stacker, allowing up to 75 plates to be dispensed automatically. Simplified programming via intuitive on-board software and a color touch screen display enable control of dispense patterns, and two integrated USB ports provide convenient file transfer and storage options.

“Microplate-based bulk dispensing can be complex, especially in an automated system,” said Jason Greene, BioTek product manager. “We specifically designed MultiFlo FX to streamline this process, providing more value through multitasking, and time savings.”

Related Links:
BioTek



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.